Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II lithium augmentation after non-response to venlafaxine or imipramine in major depression
NL-OMON25557Recruiting
- Start
- Jun 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Venlafaxine plus lithium augmentation with Imipramine plus lithium augmentation (2 arms). Primary endpoints: Proportion of responders, Change in Hamilton Rating Scale for Depression score and 1 more. Started Jun 2005; status: recruiting.
02
Drugs
lithiumvenlafaxineimipramine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON25557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25557.